Picture of ValiRx logo

VAL ValiRx News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - ValiRx PLC - Final Results <Origin Href="QuoteRef">VALX.L</Origin> - Part 2

- Part 2: For the preceding part double click  ID:nRSP3617Ka 

YEAR ENDED 31 DECEMBER 2014                
                                                    
 2                                                  Cash flows from operating activities                                                       
                                                                                                                                    2014       2013                
                                                                                                                                    £          £                   
                                                                                                                                                                   
                                                    Operating loss                                     (3,138,131)     (2,911,087)             
                                                    Depreciation of tangible assets                    517             5,623                   
                                                    Amortisation of intangible assets                  90,697          55,537                  
                                                    Increase in inventories                            (7,072)         (1,351)                 
                                                    (Increase)/decrease in receivables                 (199,884)       7,045                   
                                                    (Decrease)/(increase) in payables within one year  (158,873)       614,463                 
                                                    Other non-cash movements                           6,710           (2,782)                 
                                                    Share option charge                                89,324          -                       
                                                                                                                                    ────────   ────────            
                                                    Cash outflows from operating activities            (3,316,712)     (2,232,552)             
                                                                                                                                    ════════   ════════            
                                                                                                                                                                   
                                                                                                                                                                   
 3                                                  Cash and cash equivalents                          1 January 2014               Cash flow  31 December 2014    
                                                                                                       £                            £          £                   
                                                    Net cash:                                                          
                                                    Cash at bank and in hand                           960,267         -            (507,443)  452,824             
                                                                                                       ───────                      ───────    ───────             
                                                                                                       960,267                      (507,443)  452,824             
                                                                                                       ═══════                      ═══════    ═══════             
                                                                                                                                                                   
 
 
 VALIRX PLC                                   
                                      
 NOTES TO THE FINANCIAL STATEMENTS    
                                      
 FOR THE YEAR ENDED 31 DECEMBER 2014  
 
 
1.    Basis of Preparation 
 
The financial information set out above does not constitute the Company's
statutory accounts for the year ended 31 December 2014, but is derived from
those accounts. Statutory accounts for 2014 will be delivered to the Registrar
of Companies following the Company's annual general meeting. 
 
2.   Loss per ordinary share 
 
                                                                                                                                                                
 The earnings and number of shares used in the calculation of loss per ordinary share are set out below:  
                                                                                                                                                                
                                                                                                                                        2014        2013        
 Basic:                                                                                                   
 Loss for the financial period                                                                            (3,160,031)    (2,597,238)    
 Weighted average number of shares                                                                        3,854,730,440  1,733,106,298  
 Loss per share                                                                                           (0.08)p        (0.15)p        
                                                                                                                                        ══════════  ══════════  
                                                                                                                                                                
 There was no dilutive effect from the share options outstanding during the year (note 17).               
                                                                                                                                                                
 
 
3.    Publication of Report & Accounts 
 
The report and accounts for the year ended 31 December 2014 will be posted to
shareholders shortly and will be available from the Company's website,
www.valirx.com 
 
This information is provided by RNS
The company news service from the London Stock Exchange

Recent news on ValiRx

See all news